Dr. Jeremy Koppel Appointed to Alzheimer’s Foundation of America’s Medical, Scientific & Memory Screening Advisory Board
(January 30, 2023)— The Alzheimer’s Foundation of America (AFA) announced the appointment of Jeremy Koppel, M.D. to its Medical, Scientific & Memory Screening Advisory Board. Dr. Koppel is a longtime physician specializing in geriatric psychiatry and Co-Director at the Litwin-Zucker Center for the Study of Alzheimer’s Disease at the Feinstein Institutes for Medical Research at Northwell Health, in Manhasset.
AFA’s Medical, Scientific and Memory Screening Advisory Board is comprised of leading experts in the care, research and treatment of Alzheimer’s disease and related dementias. AFA relies on advisory board members for expert insight and opinions on scientific issues surrounding Alzheimer’s disease and related dementias, as well assistance with the development of AFA policies, programs and advocacy efforts related to research and care.
“Dr. Jeremy Koppel is a leading and distinguished researcher and physician who has devoted to his professional career to making a difference for families affected by Alzheimer’s disease,” said Charles J. Fuschillo, Jr., AFA’s President and CEO. “His three decades of experience in research and patient care, together with his passion for helping others, will make him a valuable addition to AFA’s Medical, Scientific and Memory Screening Advisory Board. We are proud to welcome him to our team.”
Dr. Koppel said, “I am honored by the opportunity to serve on the Medical, Scientific and Memory Screening Advisory Board of the Alzheimer’s Foundation of America. I look forward to working together with esteemed leaders in the field who are currently serving on the board with the aim of amplifying new research and improving the lives of patients and families suffering with Alzheimer’s disease.”
Dr. Koppel’s clinical research is focused on providing a new framework for the exploration of novel treatments for psychosis in Alzheimer’s disease. He and his team explore the underlying causes of some of the more disturbing behaviors associated with Alzheimer’s disease, including agitation, hallucinations and aggression, as a means for identifying ways to treat them. Their main area of research has been searching for the reasons why a normal brain becomes a brain with Alzheimer’s disease. Dr. Koppel is also an Associate Professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research at Northwell Health, Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and a geriatric psychiatrist at the Zucker Hillside Hospital.
Dr. Koppel has published numerous research papers and earned awards for his research, including the New York Institute of Chemists Award, the American Association for Geriatric Psychiatry (AAGP) Fellowship Award, the Herbert and Rosalie Greenberg Award for Excellence in Geriatric Psychiatry, the Herbert and Rosalie Greenberg Award for Excellence in Geriatric Psychiatry, Castle Connolly Top Doctor, and Northwell Health System Teacher of the Year. He was also named in New York Magazine 2019 “Best Doctors” issue for geriatric psychiatry.
The Alzheimer’s Foundation of America offers numerous programs and services to families affected by Alzheimer’s disease, including a Helpline staffed entirely by licensed social workers which is available seven days a week by phone (866-232-8484), text message (646-586-5283), and web chat (www.alzfdn.org). Additional information about the services is available by clicking below.
